NYSE:MOTobacco
FDA Delays Put Altria Nicotine Pouch Story Under The Microscope
US regulators have delayed decisions on several nicotine pouch products, adding fresh uncertainty to approval timelines.
The shift affects Altria Group (NYSE:MO) as it pushes further into smoke free and next generation nicotine products.
Regulators have highlighted concerns around potential use by new consumers and children, which could affect product launches and marketing plans.
For you as an investor watching NYSE:MO, this matters because the company has been putting more emphasis on...